Christianson Mark

Market Development Director

Christianson Mark has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.

On the most recent filing, Christianson Mark is listed as Market Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp. Inside the rolling window, Christianson Mark reported no open-market purchases and 6 open-market sales totaling $55K in NMTC. The largest disclosed transaction in the window is a sale of 10,000 NMTC shares on Jun 30, 2026, worth $32K.

Companies traded

Other insiders at NMTC

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$55K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
NMTCSale$32KJul 2SEC ↗
NMTCSale$11KApr 1SEC ↗
NMTCSale$654Mar 16SEC ↗
NMTCSale$80Mar 16SEC ↗
NMTCSale$9KMar 12SEC ↗
NMTCSale$2KMar 12SEC ↗
Showing 1–6 of 6
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 5, 2025NMTCSale$22K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Christianson Mark made?

Christianson Mark has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.

Which companies does Christianson Mark trade?

Christianson Mark has filed SEC Form 4 disclosures for 1 company, including NMTC.

When was Christianson Mark's most recent SEC Form 4 filing?

Christianson Mark's most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.

What is Christianson Mark's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Christianson Mark is listed as Market Development Director.

What is Christianson Mark's total buy and sell value in the current window?

Inside the rolling retention window, Christianson Mark bought $0 and sold $55K based on SEC Form 4 filings.

What was Christianson Mark's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 10,000 NMTC shares on 2026-06-30, worth $32K, per SEC Form 4 filings.